Reply to: PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-03-01
|
Series: | npj Breast Cancer |
Online Access: | https://doi.org/10.1038/s41523-023-00515-4 |